换一批Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer.
第一作者：
Yun-Gyoo,Lee
第一单位：
Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.;Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
作者：
医学主题词
抗肿瘤药(Antineoplastic Agents);顺铂(Cisplatin);女(雌)性(Female);人类(Humans);发病率(Incidence);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);多元分析(Multivariate Analysis);回顾性研究(Retrospective Studies);危险因素(Risk Factors);小细胞肺癌(Small Cell Lung Carcinoma);时间因素(Time Factors);静脉血栓栓塞(Venous Thromboembolism)
DOI
10.4143/crt.2014.045
PMID
25672586
发布时间
2022-03-31
- 浏览49
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
